Spots Global Cancer Trial Database for temozolomide injection
Every month we try and update this database with for temozolomide injection cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Camrelizumab Plus Apatinib and Temozolomide as First Line Therapy in Advanced Acral Melanoma | NCT04397770 | Melanoma | SHR1210 apatinib mesyla... Temozolomide In... | 18 Years - 75 Years | Peking University Cancer Hospital & Institute | |
| Camrelizumab Plus Apatinib and Temozolomide as First Line Therapy in Advanced Acral Melanoma | NCT04397770 | Melanoma | SHR1210 apatinib mesyla... Temozolomide In... | 18 Years - 75 Years | Peking University Cancer Hospital & Institute | |
| A Study of Toripalimab or Combining With Temozolomide（iv） in the Treatment of Advanced/Metastatic Malignant Melanoma | NCT04884997 | Malignant Melan... | toripalimab Temozolomide In... | 18 Years - 75 Years | First Affiliated Hospital of Zhejiang University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
